Acute effects of calcium sodium citrate supplementation of a test meal on mineral homeostasis, oxalate, and calcium oxalate crystallization in the urine of healthy humans - Preliminary results in patients with idiopathic calcium urolithiasis

Biomedicine and Pharmacotherapy

Volumn 53, Issue 5-6, 1999, Pages 264-273

  Herrmann, U ^a   Schwille, P O ^a   Schmiedl, A ^a   Fan, J ^a   Manoharan, M ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Acute oral load; Calcium oxalate crystallization; Calcium sodium citrate; Intestinal absorption; Mineral homeostasis; Renal stone patients; Volunteers

Indexed keywords

CALCIUM OXALATE; CITRATE CALCIUM; OXALIC ACID;

ADULT; ARTICLE; BONE MINERALIZATION; CALCITONIN BLOOD LEVEL; CALCIUM INTAKE; CALCIUM STONE; CLINICAL ARTICLE; DIET SUPPLEMENTATION; DOSE RESPONSE; FEMALE; HORMONAL REGULATION; HUMAN; INTESTINE ABSORPTION; MALE; NUTRITIONAL VALUE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RISK ASSESSMENT; UROLITHIASIS;

EID: 0033150088     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0753-3322(99)80097-3     Document Type: Article

References (46)

1. Ringe M. The risk of nephrolithiasis with oral calcium supplementation. Calcif Tissue Int 1991 ; 48 : 69.
2. Harvey JA, Zobitz MM, Pak CYC. Calcium citrate: Reduced propensity for the crystallization of calcium oxalate in urine resulting from induced hypercalciuria of calcium supplementation. J Clin Endocrinol Metab 1983 ; 61 : 1223.
3. Pak CYC, Sakhaee K. Nephrolithiasis from calcium supplementation. J Urol 1987 ; 137 : 1212.
4. Schwille PO, Schmied A, Herrmann U, Schwille R, Fink E, Manoharan M. Acute oral calcium-sodium citrate load in healthy males. Effects on acid-base and mineral metabolism, oxalate and other risk factors of stone formation in urine. Meth Find Exp Clin Pharmacol 1997 ; 19 : 417.
5. Pak CYC. Calcium bioavailability and clinical use of calcium salts. Nat Kidney Found CRN 1988 ; 12 : 8.
6. Schwille PO, Siegert R, Fries W, Wagner W, Rümenapf G, Schick CH. Orchiectomy-induced osteoporosis in the rat - A preliminary report on the state of mineral and bone metabolism, and its response to oral calcium-sodium citrate. Med Sci Res 1994 ; 22 : 529.
7. Thomas J, Thomas E, Duburque MT, Melon JM, Monsaingeon A. Experimental oxalic acid lithiasis in the rat. Influence of certain intermediates of the Krebs cycle. CR Soc Biol (Paris) 1973 ; 167 : 1761.
8. Bushinsky DA, Sessler NE. Critical role of bicarbonate in calcium release from bone. Am J Physiol 1992 ; 163 : 5-10.
9. Curreri PA, Onoda G, Finlayson B. A comparative adsorption appraisal of adsorption of citrate on whewellite seed crystals. J Cryst Growth 1981 ; 53 : 209.
10. Simpson DP. Influence of plasma bicarbonate concentration and pH on citrate excretion. Am J Physiol 1964 ; 206 : 875.
11. Schwille PO, Rümenapf G, Köhler R, Sörgel F. Effects of acute oral sodium potassium citrate load in healthy males - Outlook for treatment of patients with calcium-containing renal stones. Urol Int 1987 ; 42 : 81.
12. Fan J, Schwille PO, Schrniedl A, Gottlieb D, Manoharan M, Herrmann U. Calcium oxalate crystallization in undiluted urine of healthy males: In vitro and in vivo effects of various citrate compounds. Scann Micros 1999 ; 12, in press.
13. Schwille PO, Schmiedl A, Herrmann U, Bergé B, Kissler H, Rümenapf G. Phosphaturia and the associated metabolic activity in idiopathic recurrent calcium urolithiasis (RCU) re-examined - What do they tell us? In: Tisellus HG, ed. Renal Stones - Aspects on their Formation, Removal and Prevention. Akademitryck AB: Edsbruk; 1996. p. 86.
14. Shorr R, Bernheim AP, Taussky H. The relation of urinary citric acid excretion to menstrual cycle and the steroidal reproductive hormones. Science 1942 ; 95 : 606.
15. Wissenschaftliche tabellen geigy, Teilband Kôrperflüssigkeiten. 8th Ed, Basel, 1985 ; p. 260
16. Fan J, Schwille PO, Manoharan M, Gottlieb D, Schmiedl A. Calcium oxalate nucleation, growth and aggregation in undiluted urine of healthy controls and patients with idiopathic recurrent calcium urolithiasis evaluated by a one-time small-volume test procedure - Effects of alkali citrate. Clin Lab 1995 ; 41 : 139.
17. Smith LH, Werness PG, Erickson SD, Phillips SF. Post-prandial response to a normal diet in patients with idiopathic calcium urolithiasis. In: Ryall RL, Brockis JG, Marshall VR, Finlayson B, eds. Urinary Stone. New York: Churchill Livingstone; 1984. p. 47.
18. Schwille PO, Rümenapf G, Kôhler R. Blood levels of glucometabolic hormones and urinary saturation with stone forming phases after an oral test meal in male patients with recurrent idiopathic calcium urolithiasis and in healthy controls. J Am Coll Nutr 1989 ; 8 : 557.
19. Schwille PO, Herrmann U, Schmiedl A, Kissler H, Wipplinger J, Manoharan M. Urinary phosphate excretion in the pathophysiology of idiopathic recurrent calcium urolithiasis: Hormonal interactions and lipid metabolism. Urol Res 1997 ; 25 : 417.
20. Bergmann P, Fuss M. Comparison between the fractional isotopic calcium absorption and an oral calcium tolerance test. Calcif Tiss Int 1983 ; 15 : 819.
21. Finlayson B. Calcium stones: Some physical and clinical aspects. In: David DL, ed. Calcium in Renal Failure and Nephrolithiasis. New York: J Wiley and Sons; 1977. p. 337.
22. Marshall RW, Robertson WG. Nomograms for the estimation of the saturation of urine with calcium oxalate, calcium phosphate, magnesium ammonium phosphate, uric acid, sodium acid urate, and cystine. Clin Chim Acta 1976 ; 72 : 253.
23. Rümenapf G, Schwille PO. The influence of citrate on the duodenal absorption of calcium in the rat. Calcif Tissue Int 1988 ; 42 : 326.
24. Schwille PO, Hanisch E, Scholz D. Post-prandial hyperoxaluria and intestinal oxalate absorption in idiopathic renal stone disease. J Urol 1984 ; 132 : 650.
25. Schwille PO, Schmiedl A, Rümenapf G. Management of disorders of calcium metabolism. In: Whitfield HN, Hendry WF, Kirby RS, Duckett JW, eds. Textbook of Genito-urinary Surgery (2nd Ed). Oxford: Blackwell Science; 1998. p. 771.
26. Sharma V, Schwille PO. Effect of calcium on oxalate uptake and transport by the rat intestine. Scand J Clin Lab Invest 1992 ; 52 : 339.
27. Farley IK Hall SL, Tanner MA, Wergedal JE. Specific activity of skeletal phosphatase in human osteoblast-line cells regulated by phosphate, phosphate esters, and phosphate analogs and release of alkaline phosphatase activity inversely regulated by calcium. J Bone Min Res 1994 ; 9 : 497.
28. Lemman J. Composition of the diet and calcium kidney stones. N Engl J Med 1993 ; 328 : 880.
29. Riggs LB, O'Fallon WM, Muhs J, O'Connor MK, Kumar R, Melton LJ. Long-term effects of calcium supplementation on serum parathyroid hormone level, bone turnover, and bone loss in the elderly. J Bone Min Res 1998 ; 13 : 168.
30. Lemman J, Pleuss JA, Gray RW. Increased dietary calcium intake reduces urinary oxalate excretion in healthy adults. In: Walker VR, Sutton RAL, Cameron ECB, Pak CYC, Robertson WG, eds. Urolithiasis. New York: Plenum Press; 1989. p. 435.
31. Robertson WGR, Hughes H, Husain I, AI-Faqile S, Arafat A, Chakrabarti A, et al. Simultaneous treatment of calcium oxalate and uric acid stone disease in Saudi Arabia. In: Ryall R, Bals R, Marshall V, Rofe A, Smith LH, Walker VR, eds. Urolithiasis 2. New York: Plenum Press; 1994. p. 581.
32. Heaney RP, Weaver CM, Fitzsimmons ML. Influence of calcium load on absorption fraction. J Bone Min Res 1990 ; 5 : 1135.
33. Loannini B, Chalmers A. Calcium absorption in nephrolithiasis explained by uptake studies in ileal brush border membrane vesicles. Biochem Med Metab Biol 1994 ; 51 : 99.
34. Nicar MJ, Pak CYC. Calcium bioavailability from calcium carbonate and calcium citrate. J Clin Endocrinol Metab 1985 ; 61 : 391.
35. Pabon ML, Lönnerdal B. Effect of citrate on zinc bioavailability from milk, milk fractions and infant formulas. Nutr Res 1992 ; 13 : 103.
36. Minihane AM, Fairweather-Tait SJ. Effect of calcium supplementation on dally non-heme-iron absorption and long-term iron status. Am J Clin Nutr 1998 ; 68 : 96.
37. Andon MB, Ilich JZ, Tzagournis MA, Matkovic V. Magneslum balance in adolescent females consuming a low- or high- calcium diet. Am J Clin Nutr 1996 ; 63 : 950.
38. Quamme GE. Magnesium homeostasis and magnesium handling. Miner Electrol Metab 1993 ; 19 : 218-25.
39. Reginster IY, Dens D, Batsch V, Derosy K Zegels B, Franchimont P. Acute biochemical variations induced by four different calcium salts in healthy male volunteers. Osteoporosis Int 1993 ; 3 : 271.
40. Eriksen EF, Melsen F, Mosekilde L. Drug therapy. Formation-stimulating regimens. In: Riggs BL, Melton JL, eds. Osteoporosis: Etiology, Diagnosis, and Management (2nd Ed). Philadelphia: Lippincott-Raven; 1995. p. 403.
41. Curhan GC, Willett WC, Rimm EB, Stampfer MI. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 1993 ; 328 : 833.
42. Schmiedl A, Schwille PO. Tolerable oxalate in the urine: Principles, improvement of measuring method, and assessment in idiopathic calcium urolithiasis. Clin Lab 1994 ; 40 : 757.
43. Bisaz S, Felix K Neuman WF, Fleisch H. Quantitative determination of inhibitors of calcium phosphate precipitation in whole urine. Miner Electrol Metab 1978 ; 1 : 74.
44. Tisellus HG, Larsson L. Calcium phosphate: An important crystal phase in patients with recurrent calcium stone formation? Urol Res 1993 ; 21 : 175.
45. Barkin J, Wilson DR, Manuel MA, Bayley A, Murray T, Harrison J. Bone mineral content in idiopathic calcium urolithiasis. Miner Electrol Metab 1985 ; 11 : 19.
46. Schmiedl A, Schwille PO, Hensen J. Bone mineral density (BMD) in normocalciuric patients with idiopathic calcium urolithiasis (ICU): Possible role of urinary calcium, magnesium, phosphate, and magnesium retention from a test meal. In: Jungers P, Daudon M, eds. Renal Stone Disease. Crystallization Process, Pathophysiology, Metabolic Disorders and Prevention. Paris: Elsevier; 1997. p. 185.